De PhD y otros demonios. Sandra Bermeo
14. Jokipii L, Jokipii AM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med. 1986 Dec 25;315(26):1643-7.
15. Clavel A, Arnal AC, Sánchez EC, Cuesta J, Letona S, Amiguet JA, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection. 1996 Sep-Oct;24(5):341-6.
16. Gross TL, Wheat J, Bartlett M, O’Connor KW. AIDS and multiple system involvement with Cryptosporidium. Am J Gastroenterol. 1986 Jun;81(6):456-8.
17. Houpt ER, Bushen OY, Sam NE, Kohli A, Asgharpour A, Ng CT, et al. Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Am J Trop Med Hyg. 2005 Sep;73(3):520-2.
18. Leitch GJ, He Q. Cryptosporidiosis-an overview. J Biomed Res. 2012 Jan;25(1):1-16.
19. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY. Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Microbiol. 1983 Jul;18(1):185-90.
20. Parisi MT, Tierno PM Jr. Evaluation of new rapid commercial enzyme immunoassay for detection of Cryptosporidium oocysts in untreated stool specimens. J Clin Microbiol. 1995 Jul;33(7):1963-5.
21. Vieira-Silva C, Ferreira MS, Gonçalves-Pires MRF, Costa-Cruz JM. Detection of Cryptosporidium – specific coproantigen in human immunodeficiency virus/acquired immunodeficiency syndrome patients by using a commercially available immunoenzymatic assay. Mem Inst Oswaldo Cruz 2003; 98:1097-99.
22. Arrowood MJ, Sterling CR. Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J Clin Microbiol. 1989 Jul;27(7):1490-5.
23. Taguchi T, Shinozaki Y, Takeyama H, Haraguchi S, Yoshino M, Kaneko M, et al. Direct counting of Cryptosporidium parvum oocysts using fluorescence in situ hybridization on a membrane filter. J Microbiol Methods. 2006 Nov;67(2):373-80.
24. Bueno-Franco RM. Branco N, Guiguet-Leal, DA. Parasitologia ambiental: Métodos de concentracao e deteccao de Cryptosporidum spp. E. Giardia spp. Em amostras de água. Ver Patol Trop 2012;41(2):119-135.
25. Morgan UM, Pallant L, Dwyer BW, Forbes DA, Rich G, Thompson RC. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol. 1998 Apr;36(4):995-8.
26. Amar CF, Dear PH, McLauchlin J. Detection and identification by real time PCR/RFLP analyses of Cryptosporidium species from human faeces. Lett Appl Microbiol. 2004;38(3):217-22.
27. Robinson G, Elwin K, Chalmers RM. Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis. 2008 Nov;14(11):1800-2.
28. Fayer R, Ungar BL. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev. 1986 Dec;50(4):458-83.
29. Lengerich EJ, Addiss DG, Marx JJ, Ungar BL, Juranek DD. Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis. 1993 May;167(5):1252-5.
30. MacKenzie WR, Schell WL, Blair KA, Addiss DG, Peterson DE, Hoxie NJ, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995 Jul;21(1):57-62.
31. Kuhls TL, Mosier DA, Crawford DL, Griffis J. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis. 1994 May;18(5):731-5.
32. Perez-Schael I, Boher Y, Mata L, Perez M, Tapia FJ. Cryptosporidiosis in Venezuelan children with acute diarrhea. Am J Trop Med Hyg. 1985 Jul;34(4):721-2.
33. Esteban JG, Aguirre C, Flores A, Strauss W, Angles R, Mas-Coma S. High Cryptosporidium prevalences in health Aymara children from the Northern Bolivian Altiplano. Am J Trop Med Hyg 1998; 58(1):50-5.
34. Weikel CS, Johnston LI, De Sousa MA, Guerrant RL. Cryptosporidiosis in northeastern Brazil: association with sporadic diarrhea. J Infect Dis. 1985 May;151(5):963-5.
35. Blanco RA. Diarrea y Cryptosporidium en Guatemala. Bol Med Hosp. Infant Mex 1988; 45(3):139-43.
36. Carreño M, Velasco C, Rueda E. Prevalencia de Cryptosporidium spp. En niños menores de 13 años con afecciones oncológicas. Colombia Méd 2002;36(2) Supl 1:6-9.
37. Siuffi M, Angulo M, Velasco C, López P, Dueñas V, Rojas C. Relación entre los niveles de carga viral y los niveles de linfocitos CD4 en el diagnóstico de Cryptosporidium spp. en heces de niños de la Clínica pediátrica de VIH/SIDA del Hospital Universitario del Valle, Cali, Colombia. Colombia Méd 2006;37(1):15-20.
38. Angel VE, Franco L, Jaramillo JC, Medina LA, Ochoa FL, Vélez AM, et al. Cryptosporidiosis en Medellín. Prevalencia de Cryptosporidium en muestras fecales diarreicas en 6 laboratorios de Medellín. Estudio de 10 casos. Biomédica 1985:5:53-61.
39. Botero JH, Castaño A, Montoya MN, Ocampo NE, Hurtado MI, Lopera MM. A preliminary study of the prevalence of intestinal parasites in immunocompromised patients with and without gastrointestinal manifestations. Rev Inst Med Trop S Paulo 2003;45(4):197-200.
40. Navarro-Martínez L, da Silva AJ, Botero JH, Montoya MN, del Aguila C, Bornay-Linares FJ. Cryptosporidiosis in HIV-positive patients from Medellín, Colombia. J Eukaryot Microbiol 2006;53(Suppl 1):S37-9.
41. Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. 2008 Aug;79(2):210-4.
42. Castillo R, Gilman R, Miranda E, Echeverria M, Lembcke J, Sterling C. Anticuerpos IgA secretorios de la leche materna preotectores contra la infección por Cryptosporidium parvum. Parasitol al Día 2001; 25:3-7.
43. Pelayo L, Nuñez FA, Rojas L, Wilke H, Furuseth Hansen E, Mulder B, et al. Molecular and epidemiological investigations of cryptosporidiosis in Cuban children. Ann Trop Med Parasitol. 2008 Dec;102(8):659-69.
44. Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. 2006 Mar;4(3):320-4.
45. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis. 2005 Apr 15;40(8):1173-80.
46. Rossignol JF, Hidalgo H, Feregrino M, Higuera F, Gomez WH, Romero JL, et al. A double-’blind’ placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg. 1998 Nov-Dec;92(6):663-6.
47. Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002 Nov 2;360(9343):1375-80.
48. Botero D. Avances en el tratamiento de parasitosis intestinales. Biomédica 2007; 27 Supl 2:80-2.
49. White AC Jr, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis. 1994 Aug;170(2):419-24.
50. Smith HV, Corcoran GD. New drugs and treatment for cryptosporidiosis. Curr Opin Infect Dis. 2004 Dec;17(6):557-64.
51. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of VIH-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998; 351(9098):256-61.
Ciclosporiasis